NCT06371170View on ClinicalTrials.gov

Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population

RecruitingOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2027

Conditions

Intracardiac Thrombus

Interventions

DRUG

Rivaroxaban

Oral anticoagulation

Trial Locations (1)

60123

RECRUITING

CCPC, Ancona

All Listed Sponsors

lead

Azienda Ospedaliero, Universitaria Ospedali Riuniti

OTHER